SCHEMBL10659846

SCHEMBL10659846

Nc1ncnc2c(N3CCOCC3)nc(N3CCNCC3)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
GAA P10253 3/20 0.49
KHK P50053 1/20 0.48
PIK3CA P42336 6/20 0.45
PIK3CD O00329 1/20 0.45
PIK3CB P42338 1/20 0.45
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
POLB P06746 1/20 0.43
EEF2K O00418 1/20 0.42
HTR2C P28335 1/20 0.41
PIK3R1 P27986 3/20 0.41
ADK P55263 1/20 0.40
MTOR P42345 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
ALDH1A1 P00352 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10659879 0.83 KHK (0.47) KDM4EKHKPIK3CDPOLBHTR2C
SCHEMBL10663374 0.82 KMT2A (0.42) KDM4EKHKPIK3CAPIK3CDTSHR
SCHEMBL10660874 0.82 TSHR (0.42) KDM4EKHKPIK3CAPIK3CDPIK3CB
SCHEMBL10661157 0.81 TSHR (0.44) KDM4EGAAKHKPIK3CAPIK3CD
SCHEMBL10657925 0.81 SMN1; SMN2 (0.47) KDM4EGAAKHKPIK3CAPIK3CB
SCHEMBL9350877 0.81 KDM4E (0.51) KDM4EGAAPIK3CATSHRPIK3R1
SCHEMBL10665420 0.80 TSHR (0.41) KDM4EPIK3CAPIK3CDPIK3CBTSHR
SCHEMBL10661270 0.79 KMT2A (0.40) KDM4EGAAKHKPIK3CAPIK3CD
SCHEMBL10663939 0.79 KHK (0.44) KDM4EGAAKHKPIK3CAPIK3CD
SCHEMBL10658814 0.78 POLB (0.47) KDM4EGAAKHKPIK3CAPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4728646-A ANTITHROMBOTICS DR. KARL THOMAE GMBH (DE) 1988-03-01 US disclosed
US-4518596-A Antithrombotic use of 2-(perhydro-1,4-diazino)-pyrimido (5,4,D)-pyrimidines DR. KARL THOMAE GMBH (DE) 1985-05-21 US disclosed
EP-0023559-B1 2-(PERHYDRO-1,4-DIAZINO)-PYRIMIDO(5,4-D)PYRIMIDINES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1984-09-19 EP disclosed
EP-0023559-A1 2-(Perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1981-02-11 EP disclosed